Article info
PDFClinical science
Use of Ruthenium-106 Brachytherapy for Iris Melanoma: The Scottish Experience
- Correspondence to Dr Umiya Agraval, Tennent Institute of Ophthalmology, Gartnavel General Hospital, 1053 Great Western Road, Glasgow G12 0YN, UK; umiya.agraval{at}nhs.net
Citation
Use of Ruthenium-106 Brachytherapy for Iris Melanoma: The Scottish Experience
Publication history
- Received February 1, 2017
- Revised April 24, 2017
- Accepted April 29, 2017
- First published June 9, 2017.
Online issue publication
August 03, 2018
Article Versions
- Previous version (15 December 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.